Edgewell Personal Care
EPC
27.49
+0.62
+2.31%
Edgewell Personal Care
US · EPC
#3113 by market cap
Listed 1970
27.49
+0.62
+2.31%
Live - 5344 symbols - heartbeat 277s ago
· 2026-10-08 04:00
Pre-market
27.49
0.00%
After-hours
27.49
0.00%
- Market cap
- 1.27B
- P/E (TTM)i
- -13.81
- P/Bi
- 0.87
- EPSi
- 0.53
- Div yieldi
- 2.18%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on EPC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.65, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.34% YoY
Margins
- Gross margin
- 41.60%
- Operating margin
- 8.80%
- Net margin
- 1.14%
Key ratios & quality
- Enterprise valuei
- 2.45B
- Altman Z-Scorei
- 1.65
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.23B | 2.14B | 1.95B | 2.09B | 2.17B | 2.25B | 2.25B | 2.22B |
| Gross profit | 1.03B | 966.60M | 880.90M | 951.20M | 880.50M | 940.80M | 955.70M | 924.90M |
| Selling & admin expenses | 688.40M | 622.90M | 625.00M | 632.70M | 627.40M | 638.70M | 662.10M | 671.70M |
| Research & development | 61.10M | 53.50M | 55.30M | 57.80M | 55.50M | 58.50M | 58.40M | 57.60M |
| Operating profit | 283.40M | 290.20M | 200.60M | 260.70M | 197.60M | 243.60M | 235.20M | 195.60M |
| Pretax profit | 163.80M | -390.30M | 87.30M | 147.10M | 124.10M | 147.70M | 120.90M | 23.60M |
| Tax | 60.50M | -18.10M | 19.70M | 29.30M | 24.60M | 33.00M | 22.30M | -1.80M |
| Net profit | 103.30M | -372.20M | 67.60M | 117.80M | 99.50M | 114.70M | 98.60M | 25.40M |
| Basic EPS | 2 | -7 | 1 | 2 | 2 | 2 | 2 | 1 |
| Diluted EPS | 1.90 | -6.88 | 1.24 | 2.13 | 1.85 | 2.21 | 1.97 | 0.53 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 516.60M | 560.40M | 731.40M | 422.80M | 519.50M | 570.10M |
| Gross profit | 236.90M | 250.10M | 265.50M | 161.00M | 216.90M | 242.50M |
| Selling & admin expenses | 162.70M | 176.70M | 186.60M | 148.00M | 169.60M | 191.50M |
| Research & development | 13.40M | 13.50M | 17.40M | 13.80M | 14.90M | 13.30M |
| Operating profit | 60.80M | 59.90M | 61.50M | -800.00K | 32.40M | 37.70M |
| Pretax profit | 31.40M | 28.50M | -23.50M | -36.90M | 7.90M | 18.00M |
| Tax | 10.60M | 7.00M | -16.80M | -7.70M | 3.90M | 5.70M |
| Net profit | 29.00M | 29.10M | -30.60M | -29.20M | -10.60M | 13.70M |
| Basic EPS | 1 | 1 | -1 | -1 | 0 | 0 |
| Diluted EPS | 0.60 | 0.62 | -0.66 | -1.41 | -0.23 | 0.29 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 951.20M | 1.04B | 983.60M | 1.14B | 942.20M | 962.40M | 936.00M | 995.50M |
| Cash & ST investments | 266.40M | 341.60M | 364.70M | 479.20M | 188.70M | 216.40M | 209.10M | 225.70M |
| Inventory | 329.50M | 357.20M | 314.10M | 345.70M | 449.30M | 492.40M | 477.30M | 484.70M |
| Total assets | 3.95B | 3.42B | 3.54B | 3.67B | 3.71B | 3.74B | 3.73B | 3.76B |
| Total current liabilities | 717.00M | 659.60M | 510.50M | 536.80M | 539.50M | 523.40M | 563.60M | 565.50M |
| Short-term debt | 193.10M | 131.40M | 30.20M | 37.50M | 19.00M | 19.50M | 24.50M | 29.50M |
| Long-term debt | 1.10B | 1.10B | 1.24B | 1.23B | 1.39B | 1.36B | 1.28B | 1.38B |
| Total liabilities | 2,208,700,000.00 | 2,117,400,000.00 | 2,108,000,000.00 | 2,090,300,000.00 | 2,246,000,000.00 | 2,200,200,000.00 | 2,146,800,000.00 | 2,203,200,000.00 |
| Total equity | 1.74B | 1.30B | 1.43B | 1.58B | 1.47B | 1.54B | 1.58B | 1.55B |
| Retained earnings | 1.08B | 714.80M | 782.40M | 865.70M | 939.10M | 1.02B | 1.09B | 1.09B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.01B | 1.00B | 995.50M | 1.06B | 1.11B | 1.11B |
| Cash & ST investments | 170.10M | 199.60M | 225.70M | 223.30M | 299.70M | 397.10M |
| Inventory | 512.20M | 488.40M | 484.70M | 461.20M | 450.10M | 433.00M |
| Total assets | 3.77B | 3.79B | 3.76B | 3.77B | 3.53B | 3.54B |
| Total current liabilities | 536.30M | 567.40M | 565.50M | 497.50M | 613.80M | 603.60M |
| Short-term debt | 43.90M | 39.50M | 29.50M | 32.50M | 35.10M | 34.20M |
| Long-term debt | 1.43B | 1.37B | 1.38B | 1.52B | 1.24B | 1.25B |
| Total liabilities | 2,258,900,000.00 | 2,225,300,000.00 | 2,203,200,000.00 | 2,281,700,000.00 | 2,085,100,000.00 | 2,075,500,000.00 |
| Total equity | 1.51B | 1.57B | 1.55B | 1.49B | 1.45B | 1.46B |
| Retained earnings | 1.10B | 1.12B | 1.09B | 1.01B | 995.80M | 1.00B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 259.40M | 190.60M | 232.60M | 229.00M | 102.00M | 216.10M | 231.00M | 118.40M |
| Depreciation & amortization | 97.60M | 93.80M | 88.80M | 87.10M | 89.90M | 91.40M | 88.00M | 88.80M |
| Free cash flow | 197.40M | 132.60M | 184.90M | 172.20M | 45.60M | 166.60M | 174.50M | 41.40M |
| Dividends paid | -- | 0 | 0 | -25.60M | -32.60M | -31.50M | -30.70M | -29.30M |
| Stock buybacks / issuance | -124.40M | 0 | 0 | -9.20M | -125.30M | -75.20M | -58.50M | -90.20M |
| Ending cash balance | 266.40M | 341.60M | 364.70M | 479.20M | 188.70M | 216.40M | 209.10M | 225.70M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 45.10M | 114.80M | 74.10M | -125.90M | 54.30M | 118.70M |
| Depreciation & amortization | 21.80M | 22.10M | 23.20M | 21.30M | 19.10M | 18.60M |
| Free cash flow | 28.00M | 99.30M | 46.50M | -137.50M | 40.30M | 103.10M |
| Dividends paid | -7.30M | -7.20M | -6.90M | -7.40M | -7.10M | -7.00M |
| Stock buybacks / issuance | -35.40M | -24.50M | 0 | 0 | -15.80M | 0 |
| Ending cash balance | 170.10M | 199.60M | 225.70M | 223.30M | 299.70M | 397.10M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.93 | -24.42 | 4.94 | 7.76 | 6.48 | 7.65 | 6.31 | 1.62 |
| ROA %i | 2.54 | -10.09 | 1.94 | 3.24 | 2.67 | 3.08 | 2.64 | 0.68 |
| ROIC %i | 4.62 | -11.21 | 4.36 | 6.08 | 5.35 | 6.02 | 5.55 | 2.73 |
| 5-year avg ROE %i | 3.54 | -4.21 | -0.71 | -1.09 | 0.16 | 0.50 | 6.64 | 5.98 |
| EBIT margin %i | 10.37 | -15.31 | 7.62 | 10.25 | 8.95 | 10.05 | 8.76 | 4.35 |
| FCF / sales %i | 9.07 | 6.19 | 9.48 | 8.25 | 2.10 | 7.40 | 7.74 | 1.86 |
| Current ratioi | 1.33 | 1.58 | 1.93 | 2.12 | 1.75 | 1.84 | 1.66 | 1.76 |
| Quick ratioi | 0.76 | 0.94 | 1.16 | 1.32 | 0.74 | 0.74 | 0.66 | 0.74 |
| Debt / assetsi | 32.81 | 35.93 | 36.79 | 35.88 | 37.98 | 36.90 | 34.83 | 37.61 |
| LT debt / equityi | 63.27 | 84.22 | 88.81 | 80.86 | 94.84 | 88.33 | 80.49 | 89.07 |
| Interest coveragei | 3.41 | -5.23 | 2.43 | 3.15 | 2.72 | 2.88 | 2.58 | 1.32 |
| Revenue CAGR (3Y) %i | -2.64 | -3.22 | -5.34 | -2.24 | 0.48 | 4.92 | 2.59 | 0.79 |
| Net income CAGR (3Y) %i | -- | -- | 128.05 | 4.48 | -- | 19.27 | -5.76 | -36.56 |
| FCF CAGR (3Y) %i | 58.69 | 4.17 | -8.91 | -4.45 | -29.94 | -3.41 | 0.44 | -3.17 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.53 | 4.12 | 1.62 | 0.42 | -5.25 | -6.16 |
| ROA %i | 2.25 | 1.73 | 0.68 | 0.17 | -2.13 | -2.54 |
| ROIC %i | 4.87 | 4.25 | 2.73 | 2.04 | -1.22 | -1.82 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.22 | 7.17 | 4.35 | 3.28 | 2.12 | 1.52 |
| FCF / sales %i | 1.44 | 1.94 | 1.86 | 1.63 | 2.18 | 2.34 |
| Current ratioi | 1.89 | 1.77 | 1.76 | 2.12 | 1.81 | 1.84 |
| Quick ratioi | 0.76 | 0.74 | 0.74 | 0.91 | 0.92 | 0.97 |
| Debt / assetsi | 39.15 | 37.23 | 37.61 | 41.22 | 36.21 | 36.18 |
| LT debt / equityi | 94.66 | 87.54 | 89.07 | 102.33 | 85.93 | 85.28 |
| Interest coveragei | 2.43 | 2.08 | 1.32 | 0.99 | 0.66 | 0.50 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Wet Shave is the largest reported line at 54.87% of revenue, across 2 reported segments.
- Sun and Skin Care follows at 45.13%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Wet Shave54.87%
Sun and Skin Care45.13%
Quote time 2026-10-08 04:00:10 · For reference only, not investment advice and not tailored to your situation.